NEW TREATMENT FOR PROSTATE CANCER

Early day motion 2127, tabled 22 July 2008 by Bob Spink (UKIP). Signed by 31 members.

That this House welcomes reports of the success of early trials of Abiraterone in treating an aggressive and often fatal form of prostate cancer; notes that eight out of 10 patients who have advanced prostate cancer may see their tumours shrink and be relieved of pain simply by taking a daily pill; further notes that full trials will be undertaken and that the drug may be generally available in three or four years; further notes that this drug, if it proves its potential during full trials, could help 10,000 men who die from aggressive prostate cancer each year; and therefore calls on the Government to ensure all possible support is given to accelerate the trials and ensure that the drug is available at the earliest possible moment.

Signatures by party: Labour 16, Liberal Democrat 6, DUP 3, Conservative 2, Independent 1, Plaid Cymru 1, Social Democratic and Labour Party 1, UKIP 1.